Get started

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

Updates arrive automatically.

  • ConnectM Appoints Industry Veteran Karl Pomeroy as President of Keen Labs to Scale Commercial Growth
    PR·

    ConnectM Appoints Industry Veteran Karl Pomeroy as President of Keen Labs to Scale Commercial Growth

    ConnectM Technology Solutions, Inc. (OTCQX:CNTM) ("ConnectM" or the "Company"), a U.S.-based technology company that develops, sells and operates energy infrastructure powering the physical layer of the AI economy, today announced the appointment of Karl Pomeroy as President of Keen Labs, the Company’s wholly owned technology subsidiary, effective November 2, 2026. Mr. Pomeroy brings more than 35 years of executive leadership experience at the intersection of thermal, energy, and tech industries, including expanding national distribution and service networks, advancing electrification initiatives, and driving profitable growth. Mr. Pom

    $CNTM
  • Sysco Reports First Quarter 2027 Results; Reiterates FY27 Adjusted EPS and Local Volume Guidance
    PR·

    Sysco Reports First Quarter 2027 Results; Reiterates FY27 Adjusted EPS and Local Volume Guidance

    Sysco Corporation (NYSE:SYY) ("Sysco" or the "company") today announced financial results for its 13-week first fiscal quarter ended September 26, 2026. Key financial results for the first quarter of fiscal year 2027 include the following (comparisons are to the same period in fiscal year 2026): Sales increased 2.8%; U.S. Foodservice volume increased 2.6%; U.S. Foodservice local volume increased 2.7%;Gross profit increased 3.8% to $4.1 billion;Operating income decreased 10.4% to $717 million, and adjusted operating income increased 3.2% to $927 million1;Net earnings increased 10.5% to $526 million, and adjusted net earnings increased 4.2% to $57

    $SYY
  • Alto Neuroscience Announces Participation in Upcoming Investor Conferences
    PR·

    Alto Neuroscience Announces Participation in Upcoming Investor Conferences

    Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in the following upcoming investor conferences:Stifel 2026 Healthcare Conference, November 10-12, 2026Format: Fireside chat and one-on-one meetingsPresentation Date & Time: Wednesday, November 11 at 8:00 AM ETLocation: New York, New YorkJefferies London Healthcare Conference, November 16-19, 2026Format: Fireside chat and one-on-one investor meetingsPresentation Date & Time: Thursday, November 19 at 9:30 AM GMTLocation: London, UKThe present

    $ANRO
  • Sysco Names Brandon Sewell Chief Financial Officer
    PR·

    Sysco Names Brandon Sewell Chief Financial Officer

    Sysco Corporation (NYSE:SYY) ("Sysco" or the "company") today announced that Brandon Sewell, the Company’s Interim Chief Financial Officer since March 2026, has been named Executive Vice President and Chief Financial Officer, effective November 1, 2026. "Brandon has distinguished himself as a trusted and highly effective leader throughout his twelve years with the company, and when asked to step in as Interim Chief Financial Officer, he performed at a high level," said Kevin Hourican, Sysco’s Chair of the Board and Chief Executive Officer. "Brandon commands a deep knowledge of our business, broad financial expertise, and strong understanding of h

    $SYY
  • TransUnion Named One of TIME's America's Best Companies of 2026
    PR·

    TransUnion Named One of TIME's America's Best Companies of 2026

    TransUnion (NYSE:TRU) today announced it has been named to TIME’s America’s Best Companies 2026 list, a recognition that identifies the top-performing companies in the United States based on employee satisfaction, financial performance and sustainability transparency. TransUnion helps enable trust between consumers and businesses in areas such as credit, fraud prevention, marketing and consumer solutions. Decades of responsible data stewardship and continued investment in technology and innovation have allowed the company to expand beyond traditional credit reporting while maintaining a strong focus on ensuring consumers and organizations transac

    $TRU
  • Core Molding Technologies Reports Fiscal 2026 Third Quarter Results
    PR·

    Core Molding Technologies Reports Fiscal 2026 Third Quarter Results

    Core Molding Technologies, Inc. (NYSE:CMT) ("Core Molding", "Core" or the "Company"), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utilities industries across the United States, Canada and Mexico today reports financial and operating results for the fiscal periods ended September 30, 2026. Eric Palomaki, the Company’s President and Chief Executive Officer, said, "Our third quarter results reflect continued progress against our strategic initiatives that will shape our next phase of growth. While the quarter

    $CMT
  • Innventure to Announce Third Quarter 2026 Results on November 12, 2026
    PR·

    Innventure to Announce Third Quarter 2026 Results on November 12, 2026

    Innventure, Inc. (NASDAQ:INV) ("Innventure") today announced it will release its third quarter 2026 financial results after market close on Thursday, November 12, 2026. Management will host a conference call on the day of the release at 5:00 pm ET to discuss the results. The event will be webcast live via our investor relations website https://www.innventure.com/investors or via this link. A replay of the event webcast will be made available on Innventure’s Investor Relations website following the call. About InnventureInnventure (NASDAQ:INV) builds and scales the companies that it has founded as they commercialize new technologies. Innve

    $INV
  • Global-e to Announce Financial Results for the Third Quarter 2026 on November 18, 2026
    PR·

    Global-e to Announce Financial Results for the Third Quarter 2026 on November 18, 2026

    Global-e Online Ltd. (NASDAQ:GLBE), ), the leading global e-commerce enablement platform powering the world's most iconic brands, today announced it will report financial results for the third quarter ended September 30, 2026, before market open on Wednesday, November 18, 2026. Global-e management will host a conference call to review its financial results and outlook. Date:Wednesday, November 18, 2026Time:8:00 AM ETUnited States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time, to avoid a delay in connecting. A live webcast will be available in th

    $GLBE
  • LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
    PR·

    LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026

    LENSAR, Inc. (NASDAQ:LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2026 financial results will be released before market open on Tuesday, November 10, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Tuesday, November 10, 2026 to discuss the results and recent operational highlights. To participate by telephone, please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call. T

    $LNSR
  • City Therapeutics to Present at Upcoming November Investor Conferences
    PR·

    City Therapeutics to Present at Upcoming November Investor Conferences

    City Therapeutics, Inc. (NASDAQ:CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced that management will participate in the following investor conferences in November. Stifel 2026 Healthcare ConferenceFireside Chat: Tuesday, November 10, 2026, at 10:00 a.m. ETLocation: New York, New York Jefferies Global Healthcare Conference in LondonPresentation: Monday, November 16, 2026, at 1:00 p.m. GMTLocation: London, England Live webcasts of the fireside chat and presentation will be available on the "News & Events" page within the Investors section of the City The

    $CTY
  • Intellia Therapeutics Announces Upcoming Nexiguran Ziclumeran (nex-z) Medical Congress Presentations
    PR·

    Intellia Therapeutics Announces Upcoming Nexiguran Ziclumeran (nex-z) Medical Congress Presentations

    Presentation at AHA on Nov. 9 to highlight cardiac outcomes following a single dose of nex-z in patients with ATTRv-PN with mixed phenotype from the Phase 1 clinical trial Presentation at ISA on Nov. 18 to include up to four years of follow-up data in patients with

    $NTLA
  • Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
    PR·

    Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026

    Milestone® Pharmaceuticals Inc. (NASDAQ:MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will report its financial results for the third quarter ended September 30, 2026, and provide a business update before the market open. The announcement will be followed by a conference call and webcast for investors at 8:30 am ET. To access the live conference call, participants may register here. Conference Details: Conference Date:Friday, November 13, 2026Conference Time:8:30 am ETConference Dial-in:1-877-407-0792International Dial-in:1

    $MIST
  • 4DMT to Participate in Upcoming Investor Conferences
    PR·

    4DMT to Participate in Upcoming Investor Conferences

    4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in November and December: Guggenheim 3rd Annual Healthcare Innovation Conference: Tuesday, November 10, 2026; Fireside chat at 4:30 p.m. ETStifel 2026 Healthcare Conference: Wednesday, November 11, 2026; Fireside chat at 8:00 a.m. ETJefferies Global Healthcare Conference

    $FDMT
  • Aeries Technology to Report Second-Quarter Fiscal 2027 Results on November 5, 2026
    PR·

    Aeries Technology to Report Second-Quarter Fiscal 2027 Results on November 5, 2026

    Aeries Technology, Inc. (NASDAQ:AERT) ("Aeries" or the "Company") today announced that it will report its financial results for the quarter ended September 30, 2026, the second quarter of fiscal 2027, before the U.S. market opens on Thursday, November 5, 2026. Chief Executive Officer Ajay Khare will host an investor conference call at 8:00 a.m. Eastern Time on the same day to discuss the Company's financial results and provide an update on its business and strategic priorities. Conference Call Details Date: Thursday, November 5, 2026Time: 8:00 a.m. Eastern TimeToll-Free (US & Canada): 1-800-715-9871US/International: 1-646-307-1963Conference ID

    $AERT
  • Bolt Biotherapeutics to Participate in Upcoming Conferences
    PR·

    Bolt Biotherapeutics to Participate in Upcoming Conferences

    Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) ("Bolt" or the "Company"), a clinical-stage biotechnology company pioneering a new generation of half-life-extended multispecific antibodies designed to deliver best-in-disease therapies, today announced participation in two upcoming investor conferences. Sheila Gujrathi, M.D., Chief Strategy Officer of Bolt and Co-Founder and former Chief Executive Officer of Prana Therapies, will deliver a company presentation, followed by a fireside chat, on Tuesday, November 10, 2026, at 10:40 a.m. ET at the Stifel 2026 Healthcare Conference, and attend Jefferies Global Healthcare Conference in London, taki

    $BOLT
  • Teads and Adelaide Bring Attention-Based Media Quality Measurement and Real-Time Optimization to Teads Ad Manager
    PR·

    Teads and Adelaide Bring Attention-Based Media Quality Measurement and Real-Time Optimization to Teads Ad Manager

    Teads (NASDAQ:TEAD), the omnichannel outcomes platform, today announced the expansion of its partnership with Adelaide, the leader in attention-based media quality measurement. The integration brings Adelaide’s AU metric, which predicts a placement’s likelihood of capturing attention and driving outcomes, directly into Teads Ad Manager (TAM), enabling advertisers to measure, analyze, and optimize campaigns for media quality in real time across both web and CTV InStream formats. Through this platform integration, advertisers can activate Adelaide measurement with a single click and view real-time AU data alongside standard delivery metrics such a

    $TEAD
  • XMax Announces $30 Million Share Repurchase Program
    PR·

    XMax Announces $30 Million Share Repurchase Program

    XMax Inc. (NASDAQ:XMAX) ("XMax" or the "Company"), a distributor of contemporary furniture and artificial intelligence software and platform-based service provider, today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $30 million in aggregate purchase price of its outstanding common stock, par value $0.001 per share. Shares may be repurchased only at prices below $5.50 per share. The program will begin on a date to be determined (the "Commencement Date") after the Company has (i) publicly released its financial results for the fiscal quarter ended September 30, 2026

    $XMAX
  • Nuclear News Names Deep Isolation Director of Engineering Matt Waples to 2026 “40 Under 40” List
    PR·

    Nuclear News Names Deep Isolation Director of Engineering Matt Waples to 2026 “40 Under 40” List

    Deep Isolation Nuclear, Inc. (OTCQB:DBHL) ("Deep Isolation" or the "Company"), a leading innovator in nuclear waste disposal technology, today announced that Matt Waples, the Company’s Director of Engineering, has been named to Nuclear News’ 2026 "40 Under 40" list, recognizing emerging leaders whose technical expertise and innovation are helping shape the future of the nuclear industry. Published by the American Nuclear Society, Nuclear News’ annual "40 Under 40" program celebrates young professionals making meaningful contributions to nuclear science, technology, and industry advancement. "Matt exemplifies the technical excellence and lead

    $HAL$AMTM
  • The Gentex Sema Booth to Feature Custom Car Reveals by Ringbrothers and Classic Car Studio
    PR·

    The Gentex Sema Booth to Feature Custom Car Reveals by Ringbrothers and Classic Car Studio

    The latest Gentex Corporation (NASDAQ:GNTX) technology for automotive OEMs, accessory programs, and the aftermarket will be on display in the company’s booth at the SEMA show kicking off today in Las Vegas. In addition, Gentex tech will feature prominently on two custom car unveils: one from the world-renowned Ringbrothers, and another from the elite restoration shop, Classic Car Studio. Gentex is a long-time supplier of electro-optical products for the global automotive, aerospace, fire protection, and consumer electronics industries. It’s best known for supplying nearly every major automaker with connected-car technologies and advanced electr

    $GNTX